ArticleFrontiers in oncology2020

Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy.

Hua Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.